Where has all the lorazepam gone?

BMJ (Online)

Volumn 343, Issue 7824, 2011, Pages

  De Monteverde Robb, David J S ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIAZEPAM; LORAZEPAM; PHENYTOIN;

DRUG HALF LIFE; DRUG MARKETING; EPILEPTIC STATE; HUMAN; LETTER; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECEPTOR BINDING; TONIC CLONIC SEIZURE; UNITED KINGDOM; UNSPECIFIED SIDE EFFECT;

DRUG INDUSTRY; GREAT BRITAIN; HUMANS; LORAZEPAM; STATUS EPILEPTICUS;

EID: 84858996944     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d5955     Document Type: Letter

References (5)

1. Walker M. Status epilepticus: an evidence based guide. BMJ 2005;331:673-7. (Pubitemid 41374843)
2. Bassin S, Smith TL, Pleck TP. Clinical review: status epilepticus. Crit Care 2002;6:137-42. (Pubitemid 34296342)
3. National Clinical Guideline Centre. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care - partial update of clinical guideline 20. 2011. www.nice.org.uk/nicemedia/ live/12108/50164/50164.pdf.
4. Appleton R, Macleod S, Martland T. Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children. Cochrane Database Syst Rev 2008;3:CD001905.
5. Treiman DM, Meyers PD, Walton NY, Collins JF, Colling C, Rowan AJ, et al. A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 1998;339:792-8. (Pubitemid 28447452)